Skip to main content
Explore URMC


URMC / Obstetrics & Gynecology / Research / Current Clinical Studies

Current Clinical Studies

The faculty of Obstetrics and Gynecology regularly conduct clinical research on new devices and medications that may assist in the future health of women. Scroll down to see what we're studying and how you can participate.

Studies for Pregnant Women

Comparison of gabapentin and metoclopramide in the treatment of hyperemesis gravidarum

About the study: Double-blind clinical trial enrolling pregnant women who have received intravenous fluids and have not had much benefit with previous treatments for nausea and vomiting.  Study participants will be randomly assigned to take gabapentin (Neurontin) or metoclopramide (Reglan).  Click here for more information.
Enrolling: Yes
PI: Loralei Thornburg, MD
Contact: Sarah Caveglia, MPH or Andrea French (585) 275-9165

Studies of Polycystic Ovarian Syndrome

Prenatal Androgens and PCOS

About the Study: We are recruiting women with polycystic ovary syndrome (PCOS) for a study on whether  PCOS might be related to hormones circulating in mothers’ bodies during pregnancy. The study involves a one-time visit similar to a gynecological exam. Blood draw optional.  Payment up to $40.00 for completion of study.
Enrolling? Yes
PI: Emily Barrett, PhD
Contact: Lynda Kochman, RN, CCRC  (585) 275-4149, (585) 273-2995

Studies of Other Conditions

Global Endometrial Ablation Prospective Data Study

About the Study:  This study aims to develop a database of information about women undergoing the Novasure endometrial ablation procedure.  Subjects enrolled in this study will be asked to complete a series of questionnaires before they undergo the Novasure procedure, 6 months after the procedure, and every year after the procedure for three years.  The main purpose of the study is to gain a better understanding of the long term effects of the Novasure ablation.
Enrolling? Yes
PI: Bala Bhagavath, MD
Contact: Divya Kumar, MPH (585) 275-9204


About the Study: Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by Xpert ½ Assay, Routine PCR, and Culture. This study will see whether herpes simplex virus can reliably be detected in pregnant women at the time of their delivery. Subjects should have no active herpes lesions at enrollment, and at delivery a vaginal swab and a small blood sample will be collected. Payment for completion is $20. Sponsored by National Institutes of Allergy and Infectious Disease
Enrolling? Yes
PI: Mary Caserta, MD
Contact: Emilie Wasserman, (585) 275-3565

A current list of open clinical trials at the University of Rochester is available here.